We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Drug Inhibits Neonatal Seizures in Rodent Models

News   May 20, 2019 | Original story from Penn State

 
New Drug Inhibits Neonatal Seizures in Rodent Models

Gluconate, a small organic molecule, inhibits neonatal seizures in rodent models and could open up new avenues for the treatment of epilepsy in human newborns. The image illustrates the structure of neonatal hippocampus (green), overlaid with a typical electrophysiological trace of seizure activity, and the molecular structure of gluconate. Credit: Chen Laboratory, Penn State

 
 
 

RELATED ARTICLES

New Libido Drug Vyleesi Approved to Treat Hypoactive Sexual Desire in Women

News

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

READ MORE

How Kids Suppress Tics Could Be Key to Battling Tourette Syndrome

News

At least 20 percent of elementary school-age children develop tics such as excessive blinking. It was thought most tics go away on their own, except in rare cases. However, researchers have discovered that tics don't go away completely; rather, most children simply exhibit tics less when others are watching. Learning how they do that may help others at risk for significant tic disorders.

READ MORE

"Hidden Consciousness" Could Predict Recovery for Brain Injury Patients

News

Close analysis of EEG data reveals that nearly 1 in 7 brain-injured ICU patients shows evidence of hidden consciousness just days after injury. Patients with such signs are more likely to recover, neurologists at Columbia University and NewYork-Presbyterian have found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE